ALAB
Astera Labs, Inc.
NASDAQ: ALAB · TECHNOLOGY · SEMICONDUCTORS
$367.15
-0.09% today
Updated 2026-06-12
Market cap
$54.87B
P/E ratio
217.75
P/S ratio
60.89x
EPS (TTM)
$1.47
Dividend yield
—
52W range
$85 – $372
Volume
5.9M
Astera Labs, Inc. (ALAB) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Research-backed ALAB price target 2030 projection accounting for share dilution, balance sheet debt, and time value of money.
Current price
$367.15
Today
Analyst consensus
$243.06
-33.80% · 12M
2030 Base
$731.61
+99.27% future
NPV today
$360.41
@ 17% WACC
26 analysts:
15 Buy9 Hold0 Sell
Management guidance
Management has not provided explicit multi-year revenue targets through 2030. However, CEO Jitendra Mohan emphasized at May 2026 JPMorgan conference that Scorpio product family is in 'firm ramp' with accelerating customer deployments. Company guided Q2 2026 EPS of $0.69, implying ~$1.76B annualized run rate for FY2026. Management emphasized AI inference workloads and optical networking as TAM expansion drivers, suggesting confidence in sustained high growth beyond current consensus.
Sources: Management guidance, analyst consensus, sector analysishigh confidence
ALAB · Astera Labs, Inc. · Revenue & price projection · 2023–2030E
Actual / 2030 target Projected revenue Base case price Bull to bear range
Bear case (2030)
$387.64
NPV today: $190.96
Base case (2030)
$731.61
NPV today: $360.41
Bull case (2030)
$1,495.99
NPV today: $736.97
WallStSmart.com
ALAB financial forecast · Research-backed projections
| Metric | 2025 | 2026 (E) | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) ★ |
|---|---|---|---|---|---|---|
| Revenue | $0.9B | $1.6B | $2.5B | $3.7B | $5.1B | $6.6B |
| Revenue growth | 115.1% | 84.5% | 57.6% | 48.4% | 38.8% | 29.9% |
| Net margin | — | 32.9% | 36.0% | 38.1% | 39.4% | 40.0% |
| EPS | $1.84 | $3.01 | $5.18 | $8.12 | $11.63 | $15.28 |
| Diluted shares | — | 172M | 172M | 173M | 173M | 173M |
| Net debt | — | $-1.14B | $-1.11B | $-1.07B | $-1.02B | $-946.27M |
| P/S multiple | — | 19.0x | 19.0x | 19.0x | 19.0x | 19.0x |
| Implied price (base) | — | $180.45 | $279.70 | $410.87 | $566.01 | $731.61 |
★ 2030E is the model's terminal target year. Implied price = (Revenue × P/S − Net debt) ÷ Diluted shares.
Scenario detail · Three drivers, three outcomes
| 2030E driver | Bear | Base | Bull |
|---|---|---|---|
| Revenue | $6.6B | $6.6B | $6.6B |
| P/S multiple | 10.0x | 19.0x | 39.0x |
| Diluted shares | 173M | 173M | 173M |
| Net debt | $-946.27M | $-946.27M | $-946.27M |
| Implied P/E † | 25x | 48x | 98x |
| 2030 Price | $387.64 | $731.61 | $1,495.99 |
| NPV @ 17% | $190.96 | $360.41 | $736.97 |
† Implied P/E: Multiples remain elevated across all three scenarios because ALAB is valued primarily on revenue scale during its growth phase, not near-term earnings power. Lower P/E in the bear case reflects multiple compression, but the absolute level stays high since 2030E still represents a hypergrowth-to-mature transition year.
EV to per-share bridge · How we get to $731.61 base case
ALAB catalysts and risks
Growth catalysts
+ Scorpio X-Series 320-Lane Smart Fabric Switch ramp and customer adoption acceleration through 2027-2028
+ AI inference workload migration (higher margin than training) driving incremental TAM and customer concentration diversification
+ Optical networking expansion (P-Series portfolio) entering production 2027, addressable to hyperscaler capex plans ($300B+ annually through 2028)
+ Hyperscaler AI capex commitments (Meta $60B, Microsoft $80B, Google $40B+ annually) translating to networking silicon demand
+ Gross margin stabilization/expansion as Scorpio X scales and optical products reach volume
Key risks
- Customer concentration risk: Heavy reliance on 2-3 hyperscalers (~60-70% of revenue implied); loss of single customer could reduce revenue 20-30%
- Competitive intensity from Marvell, Broadcom, established players entering AI connectivity; pricing/margin compression if differentiation erodes
- AI capex cycle volatility and potential demand cliff if hyperscaler spending moderates unexpectedly post-2027
- Valuation risk: P/E of 151x implies extreme growth expectations; any miss could trigger 30-50% correction
- Supply chain/manufacturing risk: Dependent on foundry partners (TSMC); geopolitical constraints could disrupt ramp
Methodology · Astera Labs, Inc. 2030 stock forecast model
Astera Labs, Inc. 2030 price target is calculated using WallStSmart's research model. Revenue projections are derived from analyst consensus across 26 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts. The model is built on five core components:
| 1. Share dilution | Projected from per-ticker schedule of SBC + equity raise activity, compounding year by year (1% cumulative for ALAB by 2030) |
| 2. Net debt | EV minus net debt yields equity value; debt projected from capex cycle trajectory ($-946.27M by 2030) |
| 3. Time value | NPV calculated using 17% WACC (sector fallback) |
| 4. Multiple framework | P/S compresses with scale: bear 10.0x / base 19.0x / bull 39.0x |
| 5. Scenario design | Bull/Base/Bear vary revenue, margin, shares, debt, and multiple independently |
WallStSmart research model · Not financial advice · Past performance is not indicative of future results · Last researched: May 20, 2026.
ALAB price target FAQ
What is the ALAB price target for 2030?
WallStSmart's Astera Labs, Inc. 2030 base case is $731.61 per share, with a bull case of $1,495.99 and bear case of $387.64. The NPV of the base case discounted to today at 17% WACC is $360.41.
How is the Astera Labs, Inc. 2030 stock forecast calculated?
The ALAB 2030 projection multiplies projected revenue by a growth-adjusted P/S multiple to derive enterprise value, subtracts projected net debt to get equity value, then divides by diluted shares outstanding accounting for dilution from stock-based compensation and equity raises.
Why does the ALAB price target account for dilution?
Astera Labs, Inc. is projected to grow diluted share count from 171M to 173M by 2030 (a 1% increase) through stock-based compensation and capital raises. Ignoring this would inflate the price target by approximately 1%.
What is the analyst consensus on ALAB stock?
26 analysts cover ALAB with an average 12-month price target of $243.06. The 2030 projection extends this framework with longer-horizon assumptions including dilution and time value of money.